Quantcast

C.R. Bard and Teleflex Benefit from New Antimicrobial Catheter, Power PICC and Tip Location Technologies in $3 Billion Vascular Access Market

April 12, 2011

New Catheter Placement Technologies Fuel Bedside Nurse PICC Placement
Procedures

VANCOUVER, April 12 /PRNewswire/ – According to a new report by iData Research
(www.idataresearch.net), the leading global authority in medical device market research, the
U.S. vascular access device market will reach over $4.8 billion by
2017, fueled by the adoption of new antimicrobial technologies for
central venous catheters (CVCs), dialysis catheters, peripherally
inserted central catheters (PICCs) and increased use of power
injectable PICCs. Newly released ultrasound and tip-location devices,
designed to assist with catheter placement, will also drive growth in
the overall vascular access market. The report states that the
ultrasound guidance and tip-location market will almost triple in value
by 2017.  

“Teleflex and C.R. Bard now have new FDA approved tip-location systems
that are indicated to eliminate the need for costly and time consuming
X-ray procedures, traditionally required for confirmation of correct
placement,” says Dr. Kamran Zamanian, CEO of iData. “As a result, these
systems are expected to facilitate greater bedside PICC placement by
nurses. Not only do such PICC kits sell at a premium relative to
radiology-kits but key manufacturers are also bundling tip-location
technologies with their nurse-kits, thereby further increasing
per-patient revenue.”

The report also states that clinicians are adopting power PICCs, capable
of injecting contrast agents, at a rapid rate as computed tomography
(CT) scans are becoming more prevalent. By 2017, approximately 20% of
patients who receive PICCs are also expected to receive a CT scan
driving increased adoption of power PICCs.

In addition, new catheters incorporating antimicrobial technologies to
reduce catheter-based blood stream infections, are gaining increased
adoption. Companies such as Teleflex, Cook and C.R. Bard have leveraged
antimicrobial technology to develop antimicrobial CVCs, PICCs, and
dialysis catheters, which are driving sales in the vascular access
market.  

iData’s report entitled: “U.S. Market for Vascular Access Devices and Accessories 2011″ includes the latest data, market analyses and competitor profiles for
over 65 market segments.

For more information, register free on iData’s website at: http://www.idataresearch.net/idata/registration.php

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on
providing market intelligence for medical device, dental and
pharmaceutical companies. iData covers research in: vascular access,
diabetes, cardiology, and more.

SOURCE iData Research Inc.


Source: newswire



comments powered by Disqus